Sermsiri Sangroongruangsri
Overview
Explore the profile of Sermsiri Sangroongruangsri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malasai K, Jittikoon J, Udomsinprasert W, Talungchit P, Youngkong S, Sangroongruangsri S, et al.
Clinicoecon Outcomes Res
. 2025 Feb;
17:33-43.
PMID: 39931251
Purpose: This study aimed to evaluate the costs and benefits of genetic testing, specifically mutation analysis and prenatal diagnostic testing, for the confirmation of thalassemia in at-risk pregnancies in Thailand,...
2.
Nagi M, Ahmed H, Rezq M, Sangroongruangsri S, Chaikledkaew U, Almalki Z, et al.
Int J Obes (Lond)
. 2023 Oct;
48(1):33-43.
PMID: 37884664
Introduction: Obesity is a growing public health problem leading to substantial economic impact. This study aimed to summarize the economic impact of obesity and to critically analyze the methods used...
3.
Wongkrajang P, Jittikoon J, Udomsinprasert W, Talungchit P, Sangroongruangsri S, Turongkaravee S, et al.
PLoS One
. 2023 Sep;
18(9):e0291622.
PMID: 37713438
Historically, there has been a lack of cost-effectiveness data regarding the inclusion of universal non-invasive prenatal testing (NIPT) for trisomy 21, 18, and 13 in the benefit package of the...
4.
Wongkrajang P, Jittikoon J, Sangroongruangsri S, Talungchit P, Ruangvutilert P, Panchalee T, et al.
PLoS One
. 2023 Apr;
18(4):e0284829.
PMID: 37079630
This study evaluated prenatal screening test performance and the prevalence of common aneuploidies at Siriraj Hospital, Thailand. We collected data from screening tests which are first-trimester test, quadruple test, and...
5.
Srisubat A, Kittrongsiri K, Sangroongruangsri S, Khemvaranan C, Shreibati J, Ching J, et al.
Ophthalmol Ther
. 2023 Feb;
12(2):1339-1357.
PMID: 36841895
Introduction: Deep learning (DL) for screening diabetic retinopathy (DR) has the potential to address limited healthcare resources by enabling expanded access to healthcare. However, there is still limited health economic...
6.
Nagi M, Rezq M, Sangroongruangsri S, Thavorncharoensap M, Dewi P
Glob Health Res Policy
. 2022 Jul;
7(1):25.
PMID: 35879742
Introduction: Economic evaluation studies demonstrate the value of money in health interventions and enhance the efficiency of the healthcare system. Therefore, this study reviews published economic evaluation studies of public...
7.
Nagi M, Dewi P, Thavorncharoensap M, Sangroongruangsri S
Appl Health Econ Health Policy
. 2021 Dec;
20(3):315-335.
PMID: 34931297
Introduction: Due to the increase in healthcare budget constraint, economic evaluation (EE) evidence is increasingly required to inform resource allocation decisions. This study aimed to systematically review quantity, characteristics, and...
8.
Sangroongruangsri S, Chaikledkaew U, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P
Clinicoecon Outcomes Res
. 2021 Nov;
13:917-926.
PMID: 34795492
Purpose: The aim of this study was to estimate the cost-utility and budget impact of pharmacological treatments for the eye with polypoidal choroidal vasculopathy (PCV) in Thailand. Methods: A Markov...
9.
Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U
Clinicoecon Outcomes Res
. 2021 Aug;
13:703-715.
PMID: 34349534
Purpose: Type 1 hepatorenal syndrome (type 1 HRS) or hepatorenal syndrome-acute renal injury (HRS-AKI) leads to high short-term mortality rates in patients with cirrhosis. Vasoconstrictor therapy effectively improves survival of...
10.
Ruamviboonsuk P, Chantra S, Seresirikachorn K, Ruamviboonsuk V, Sangroongruangsri S
Asia Pac J Ophthalmol (Phila)
. 2021 Jul;
10(3):307-316.
PMID: 34261102
Artificial intelligence (AI) is expected to cause significant medical quality enhancements and cost-saving improvements in ophthalmology. Although there has been a rapid growth of studies on AI in the recent...